|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.388 SEK | -0.43% |
|
-0.43% | -29.54% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.43% | -0.43% | +11.76% | -11.37% | -29.54% | -61.76% | -82.52% | -97.17% | - | 21.41M | ||
| -2.48% | -6.72% | +1.72% | +24.94% | +7.24% | +44.19% | +156.43% | +387.64% | +1,330.13% | 1,054B | ||
| -1.52% | -5.01% | +5.39% | +5.73% | +22.66% | +61.87% | +58.79% | +48.96% | +106.08% | 621B | ||
| -1.30% | -3.88% | +7.49% | +16.42% | +7.13% | +27.81% | +79.97% | +108.57% | +284.75% | 438B | ||
| -1.12% | -3.68% | -0.91% | +2.80% | -0.37% | +26.89% | +20.58% | -8.02% | +28.69% | 325B | ||
| -1.73% | -3.45% | +0.28% | +1.78% | +11.70% | +26.95% | +44.09% | +44.23% | +52.17% | 281B | ||
| -1.95% | -13.92% | -8.16% | -17.12% | -10.34% | +15.96% | +19.76% | +42.62% | +176.63% | 262B | ||
| -1.45% | -2.37% | +11.30% | +29.88% | -1.71% | -27.87% | -39.87% | +16.98% | +72.53% | 219B | ||
| -1.44% | -3.49% | +0.01% | +1.23% | +8.54% | +19.60% | +56.20% | +45.18% | +118.29% | 195B | ||
| -1.04% | -4.63% | +3.54% | -7.41% | +5.95% | +16.01% | +68.47% | +91.43% | +52.02% | 163B | ||
| -0.94% | +0.75% | -7.48% | -10.55% | -2.61% | -4.34% | -33.23% | -39.30% | -34.32% | 140B | ||
| -0.82% | -8.80% | +7.05% | +7.21% | +5.06% | +0.84% | +35.03% | +140.69% | +440.34% | 122B | ||
| -4.03% | -1.76% | -0.32% | -1.95% | +5.58% | +20.30% | -8.06% | -16.10% | -25.82% | 121B | ||
| -2.08% | -0.37% | -1.42% | -6.81% | -8.73% | -9.62% | -19.42% | -14.85% | -0.17% | 106B | ||
| -1.69% | -4.12% | -3.20% | -12.31% | +5.26% | +34.82% | +45.47% | +6.86% | -5.66% | 104B | ||
| -1.20% | -2.60% | -3.69% | -17.36% | -13.21% | +4.45% | +83.06% | +73.64% | +464.79% | 73.3B | ||
| -1.60% | -3.35% | +35.73% | +20.96% | +32.72% | +78.55% | -2.37% | -3.69% | -47.43% | 55.91B | ||
| -1.67% | -0.98% | +13.05% | -2.42% | -7.97% | -4.18% | +15.36% | -8.80% | +244.55% | 54.26B | ||
| -1.01% | -3.27% | +3.64% | -6.74% | +9.06% | +18.63% | +22.91% | +40.35% | +20.53% | 51.76B | ||
| -1.29% | -1.40% | +6.98% | +0.87% | -3.87% | -1.88% | +14.65% | - | - | 43.02B | ||
| Average | -1.33% | -2.81% | +4.14% | +0.89% | +2.13% | +14.36% | +26.77% | +45.22% | +182.12% | 221.34B | |
| Weighted average by Cap. | -1.02% | -4.35% | +2.57% | +8.17% | +6.51% | +28.89% | +64.14% | +125.59% | +410.82% |
- Stock Market
- Stocks
- IRLAB A Stock
- Sector IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
















